The French National Authority for Health (HAS) published new set of decisions about add-on reimbursement for medical devices in second half of November

14

Dec 2017

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 8 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in the second half of November.

Four decisions concerned orthopedic devices:

  • Dynamic Carbon Foot 1H04Y, prosthetic foot (II energy class) (application for registration, approved)
  • HIGHLANDER, prosthetic foot (III energy class) (renewal of registration, approved)
  • SILHOUETTE, prosthetic foot (III energy class) (renewal of registration, approved)
  • PROMENADE , prosthetic foot (III energy class) (renewal of registration, approved)

Two negative decisions were released for coronary stents:

  • ABSORB GT1,  coronary stent coated with everolimus (application for registration, rejected due to insufficient expected benefit (AS))
  • ABSORB,  coronary stent coated with everolimus (application for registration, rejected due to insufficient expected benefit (AS))

Two decisions for other devices were published:

See list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more